FDA Clears Second Remicade Biosimilar (Renflexis) FDA Clears Second Remicade Biosimilar (Renflexis)
The FDA approves infliximab-abda (Renflexis, Samsung Bioepis) for multiple indications.FDA Approvals
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Alert Source Type: news